Submit Your Proposal Today - Due Friday, March 15, 2024

We are currently accepting speaking proposals for BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US Conference & Exhibition, and Well Characterized Biologics & Biological Assays (September 23-26, 2024 in Boston).

If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following topic areas:

  • Cell Culture & Upstream Processing
  • Cell Line Development & Engineering
  • Recovery & Purification
  • Manufacturing Strategy
  • Bioprocessing/Industry 4.0 & Smart Facilities
  • Single-Use/Flexible Facilities
  • Intensified & Continuous Processing
  • Bioprocess Analytics & Control Strategies
  • Raw Materials
  • Analytical & Quality
  • Cell Therapy Manufacturing
  • Gene Therapy Manufacturing
  • Preclinical/Clinical Development for CGTS
  • Early Stage Advances Therapeutics
  • Non-Viral Delivery Development & Manufacturing
  • CGT Supply Chain, Logistics, Delivery, Market Access
  • Well Characterized Biologics & Biological Assays

Questions about submitting a speaker proposal? 

For Bioprocess/Well Characterized Biologics Enquiries - Contact Barry Walsh at barry.walsh@informa.com


For Cell & Gene Therapy related Enquires – Contact Harry Starkey at harry.starkey@informa.com


Submit a Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Terms and Conditions

† You may still receive emails from us regarding any current registrations or orders.